Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Astellas adotta Veeva CRM per la distribuzione in Europa


News provided by

Veeva Systems

Sep 07, 2011, 01:00 ET

Share this article

Share toX

Share this article

Share toX

BARCELLONA, Spagna, September 7, 2011 /PRNewswire/ --

Veeva festeggia il suo 100º cliente nel mondo

Veeva Systems ha annunciato oggi stesso che Astellas Pharma Europe Ltd., la società affiliata europea di Astellas Pharma Inc., ha scelto Veeva CRM come standard CRM europeo per oltre 2.000 utenti in 20 paesi diversi. Alla ricerca di soluzioni CRM innovative per il suo nuovo modello commerciale in sviluppo in Europa, Astellas ha effettuato un processo di revisione accurato, valutando sia le offerte di prodotti attuali che futuri di ogni singolo fornitore CRM di rilievo.

"Per poter emergere nel concorrenziale settore farmaceutico europeo di oggi è necessario adottare un approccio commerciale totalmente diverso. Per sostenere il nostro nuovo modello commerciale, abbiamo voluto che la soluzione CRM fosse effettivamente distribuita in tutta Europa, a prova di futuro e abbastanza duttile da adattarsi alle nostre crescenti esigenze organizzative future. Veeva CRM è stata l'unica soluzione in grado di soddisfare tutte le esigenze aziendali", ha commentato Wim Kockelkoren, Vice Presidente senior EMEA Commercial Effectiveness e CEE regionale di Astellas Pharma Europe.  

Peter Hurst, Vice Presidente ISS, Astellas Pharma Europe, ha aggiunto, "Abbiamo scelto Veeva CRM per la sua architettura SaaS per più utenti, per i suoi costi ridotti e la maggiore trasparenza, nonché per la sua flessibilità. Siamo molto contenti di avere finalmente Veeva a bordo come uno dei partner di soluzioni IT più significative".

Veeva Systems si è affermata rapidamente come fornitore leader di soluzioni farmaceutiche CRM a livello mondiale e accoglie l'arrivo di Astellas come il suo 100º cliente. Con sedi dislocate in tutto il mondo e oltre 200 dipendenti, la crescita di Veeva è la prova della diffusa adozione in tutto il settore farmaceutico delle tecnologie cloud.  

"Astellas è già un ottimo cliente di Veeva negli Stati Uniti e noi siamo lieti di allargare questa partnership in Europa", ha dichiarato Dan Goldsmith, direttore generale, Veeva Europa. "La nostra organizzazione europea e le nostre soluzioni sono state realizzate per soddisfare le esigenze dei nostri clienti sia a livello locale che regionale. Siamo convinti che questo approccio porterà un concreto successo commerciale per Astellas in Europa", ha infine dichiarato Goldsmith.  

Informazioni su Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., con sede nel Regno Unito, è una società affiliata di Astellas Pharma Inc. con sede a Tokyo. Astellas è un'azienda farmaceutica impegnata a migliorare la salute delle persone in tutto il mondo mediante la fornitura di prodotti farmaceutici innovativi e affidabili. L'organizzazione punta a diventare un'azienda a livello mondiale combinando le straordinarie capacità di R&S e marketing e continuando a crescere nel mercato farmaceutico mondiale. Astellas Pharma Europe Ltd. è responsabile per le sue 21 sedi affiliate dislocate in tutta Europa, in Medio Oriente e in Africa, nella sede di R&S e in tre impianti di produzione. L'azienda si avvale della collaborazione di circa 4000 dipendenti dislocati in questi paesi. Per maggiori informazioni su Astellas Pharma Europe, visitare http://www.astellas.eu.

Informazioni su Veeva CRM

La suite di applicazioni Veeva CRM composta da VBioPharma, iRep, VMobile e VInsights, è la soluzione CRM basata su tecnologie cloud a livello mondiale leader nel settore farmacologico e delle biotecnologie. Inoltre, iRep si è rapidamente affermata come la soluzione del settore per il marketing a circuito chiuso su iPad. Veeva CRM è l'unica in grado di soddisfare le specifiche esigenze dei diversi team commerciali con un'unica soluzione, migliorando la fidelizzazione da parte dei clienti e il numero di vendite e riducendo allo stesso tempo i costi e la complessità. Veeva CRM è diventata la base sulla quale il settore farmaceutico incrementerà le vendite e la commercializzazione di modelli per il futuro.

Informazioni su Veeva Systems

Veeva Systems è il leader nelle soluzioni baste su tecnologie cloud per il settore delle scienze biologiche a livello globale. Attenta all'innovazione, all'eccellenza dei prodotti e alla soddisfazione dei clienti, Veeva vanta oltre 100 clienti, appartenenti alle aziende farmaceutiche più grandi al mondo fino a quelle delle biotecnologie emergenti. Nata nel 2007, Veeva è un'azienda privata con sede nella baia di San Francisco, con uffici a Filadelfia, Barcellona, Parigi, Pechino, Shanghai e Tokyo. Per ulteriori informazioni, visitare http://www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. Tutti i diritti riservati. Veeva e il logo Veeva sono marchi commerciali registrati di Veeva Systems. Veeva Systems possiede altri marchi commerciali registrati e non registrati. Altri nomi utilizzati all'interno di questo documento potrebbero essere marchi commerciali dei rispettivi proprietari.

Contatti con i media
Selma Nawaz
Direttore marketing in Europa
Veeva Systems
+34-93-1870200
[email protected]

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Veeva und BioMarin schließen langfristige strategische Partnerschaft

Veeva und BioMarin schließen langfristige strategische Partnerschaft

Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinbarung bekannt, die auf ihrer...

Veeva et BioMarin forment un partenariat stratégique à long terme

Veeva et BioMarin forment un partenariat stratégique à long terme

Veeva Systems (NYSE : VEEV) et BioMarin Pharmaceutical Inc. (NASDAQ : BMRN) ont annoncé la conclusion d'un accord d'entreprise à long terme dans le...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Networks

Networks

Networks

Networks

Computer Software

Computer Software

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.